186 related articles for article (PubMed ID: 36096044)
1. MicroRNAs and cancer-associated fibroblasts in the tumour microenvironment of oral squamous cell carcinoma (OSCC).
Chandralekha Selvakumar S; Auxzilia Preethi K; Sekar D
Oral Oncol; 2022 Nov; 134():106124. PubMed ID: 36096044
[No Abstract] [Full Text] [Related]
2. Cancer-associated fibroblasts in the invasive tumour front promote the metastasis of oral squamous cell carcinoma through MFAP5 upregulation.
Wang Y; Wang R; Li B; Huang Z; Zhao S; Chen S; Lan T; Ren S; Wu F; Tan J; Li J
Gene; 2023 Aug; 876():147504. PubMed ID: 37217152
[TBL] [Abstract][Full Text] [Related]
3. Single-cell analysis reveals that cancer-associated fibroblasts stimulate oral squamous cell carcinoma invasion via the TGF-β/Smad pathway.
Yang W; Zhang S; Li T; Zhou Z; Pan J
Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 55(2):262-273. PubMed ID: 36148955
[TBL] [Abstract][Full Text] [Related]
4. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y
Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.
Selvakumar SC; K Auxzilia P; Dinesh Y; Senthilmurugan M; Sekar D
Oral Oncol; 2022 Jul; 130():105925. PubMed ID: 35606273
[No Abstract] [Full Text] [Related]
6. Analysis of mRNA-miRNA interaction network reveals the role of CAFs-derived exosomes in the immune regulation of oral squamous cell carcinoma.
Wang WZ; Cao X; Bian L; Gao Y; Yu M; Li YT; Xu JG; Wang YH; Yang HF; You DY; He YW
BMC Cancer; 2023 Jun; 23(1):591. PubMed ID: 37365497
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol and miR-200c: insights into the prevention of oral squamous cell carcinoma.
Jayaraman S; Fathima SJ; Veeraraghavan VP; Raj AT; Patil S
Future Oncol; 2022 Oct; 18(31):3471-3472. PubMed ID: 36268781
[No Abstract] [Full Text] [Related]
10. Cancer‑associated fibroblast‑derived exosomal miR‑382‑5p promotes the migration and invasion of oral squamous cell carcinoma.
Sun LP; Xu K; Cui J; Yuan DY; Zou B; Li J; Liu JL; Li KY; Meng Z; Zhang B
Oncol Rep; 2019 Oct; 42(4):1319-1328. PubMed ID: 31364748
[TBL] [Abstract][Full Text] [Related]
11. Oral Squamous Cell Carcinoma-Derived ANGPTL3 Induces Cancer Associated Fibroblastic Phenotypes in Surrounding Fibroblasts.
Kim JY; Moon S; Kim D
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4315-4322. PubMed ID: 36580015
[TBL] [Abstract][Full Text] [Related]
12. Profiling and Functional Analysis of microRNA Deregulation in Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma Depicts an Anti-Invasive Role of microRNA-204 via Regulation of Their Motility.
Rajthala S; Min A; Parajuli H; Debnath KC; Ljøkjel B; Hoven KM; Kvalheim A; Lybak S; Neppelberg E; Vintermyr OK; Johannessen AC; Sapkota D; Costea DE
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769388
[No Abstract] [Full Text] [Related]
13. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
14. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
15. miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment.
Kawakubo-Yasukochi T; Morioka M; Hazekawa M; Yasukochi A; Nishinakagawa T; Ono K; Kawano S; Nakamura S; Nakashima M
Mol Carcinog; 2018 Feb; 57(2):295-302. PubMed ID: 28981169
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Integrated Single-Cell Whole Transcriptome Analysis Revealed the p-EMT Tumor Cells-CAFs Communication in Oral Squamous Cell Carcinoma.
Huynh NC; Huang TT; Nguyen CT; Lin FK
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742914
[TBL] [Abstract][Full Text] [Related]
18. Circ_0058063 contributes to oral squamous cell carcinoma development by sponging miR-145-5p and upregulating SERPINE1.
Yu J; Lou Y; Hou M; Ma X; Wang L
J Oral Pathol Med; 2022 Aug; 51(7):630-637. PubMed ID: 35778962
[TBL] [Abstract][Full Text] [Related]
19. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
20. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
